APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/08/2026
Voltar para busca
Dado oficial do USPTO
NE1-ELITE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
10/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
18/09/2018
Data de registro
05/11/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/11/2019
Última transação
10/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
MELBOURNE, AU
Examinador
RUTLAND, BARBARA A
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Invictus Biotechnology Pty Ltd
Representantes
Lindsay J. Hulley Rutan & Tucker, LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Dietary food supplements; dietary nutritional supplements; dietary protein supplements; dietary supplements; energy drinks in the nature of dietary supplement drinks; herbal dietary supplements; plant compounds for use as dietary supplements for medicinal purposes; plant extracts sold as components of dietary supplements; protein dietary supplements; dietetic food supplements adapted for medical purposes; food supplements for medical purposes; medicated food supplements; medicated preparations for use as supplements for food; medicated supplements for food; medicated supplements for foodstuffs for human consumption; medicinal food supplements; nutritional supplements; nutritional supplements for medical use; protein supplements for humans; nutritional supplements containing trace elements for foodstuffs for human consumption; vitamin preparations in the nature of food supplements; vitamin supplements; vitamin supplements for foodstuffs for human consumption; preparations of vitamins; stimulants made of vitamins for improving exercise performance; vitamin drinksdietary supplemental drinks in the nature of vitamin beverages; vitamin preparations; vitamin preparations for human consumption; vitamin preparations in tablet form; vitamin tablets; vitamins; capsules sold empty for medicines; medicines for muscle injuries and disorders and sports related injuries and for improving exercise endurancecapacity and performance for human purposes; medicines for human use for muscle injuries and disorders and sports related injuries and for improving exercise endurancecapacity and performance; medicines for preventing muscle injuries and disorders and sports related injuries ailments; medicines for treatment of the heart; medicinal preparations for the mouth to be applied in the form of tablets; tablets for medicinesdrug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations in the form of tablets for the prevention of muscle injuries and disorders and sports related injuries; pharmaceutical preparations in the form of tablets for improving exercise endurancecapacity and performance; pharmaceutical tablets for muscle injuries and disorders and sports related injuries and for improving exercise endurancecapacity and performance; specialized tablets for the delivery of pharmaceuticals sold without the pharmaceutical ingredient
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
ES75
TEAS SECTION 71 & 15 RECEIVED
05/05/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/11/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
20/03/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/03/2020
FIMP
FINAL DISPOSITION PROCESSED
29/02/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/02/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/08/2019
PUBO
PUBLISHED FOR OPPOSITION
20/08/2019
GPNX
NOTIFICATION PROCESSED BY IB
16/08/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/07/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
31/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/07/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
18/07/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/07/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
18/07/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2019
ALIE
ASSIGNED TO LIE
01/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/06/2019
RFNT
REFUSAL PROCESSED BY IB
08/02/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/01/2019
RFRR
REFUSAL PROCESSED BY MPU
17/01/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/01/2019
CNRT
NON-FINAL ACTION WRITTEN
07/01/2019
DOCK
ASSIGNED TO EXAMINER
28/12/2018
MAFR
APPLICATION FILING RECEIPT MAILED
04/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/11/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/11/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NE1-ELITE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.